Enhancer ID: | E_02_0613 |
Species: | human |
Position : | chr20:3079786-3081786 |
Biosample name: | |
Experiment class : | High+Lowthroughput |
Enhancer type: | Enhancer |
Disease: | Neuromuscular diseases (certain neuromuscular disorders) |
Pubmed ID: | 31461843 |
Enhancer experiment: | PCR, Western blot, gene knockdown, gel electrophoresis |
Enhancer experiment description: | Arginine-vasopressin (AVP) promotes muscle differentiation, hypertrophy, and regeneration through the combined activation of the calcineurin and Calcium/Calmodulin-dependent Protein Kinase (CaMK) pathways. |
Target gene : | AVP |
Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: | RNA-Seq |
Target gene experiment description: | Arginine-vasopressin (AVP) promotes muscle differentiation, hypertrophy, and regeneration through the combined activation of the calcineurin and Calcium/Calmodulin-dependent Protein Kinase (CaMK) pathways. |
TF name : | -- |
TF experiment: | PCR,Western blot,????,???? |
TF experiment description: | Arginine-vasopressin (AVP) promotes muscle differentiation, hypertrophy, and regeneration through the combined activation of the calcineurin and Calcium/Calmodulin-dependent Protein Kinase (CaMK) pathways. |
Enhancer function : | Arginine-vasopressin (AVP) promotes muscle differentiation, hypertrophy, and regeneration through the combined activation of the calcineurin and Calcium/Calmodulin-dependent Protein Kinase (CaMK) pathways. |
Enhancer function experiment: | Immunohistochemical staining |
Enhancer function experiment description: |
Arginine-vasopressin (AVP) promotes muscle differentiation, hypertrophy, and regeneration through the combined activation of the calcineurin and Calcium/Calmodulin-dependent Protein Kinase (CaMK) pathways. |
SNP ID: | -- |
GeneName | Pathway Name | Source | Gene Number |
---|